New & Improved!

September-October 2014
Volume: 3 Number: 5
Articles: 6

pg. 1
Past Effort Pays Dividends!
pg. 2
Addressing Real and Perceived Clinical Lab Analytical Errors
pg. 6
Identifying Lab Errors that Lead to Lawsuits
pg. 12
Comprehensive Screening for Sexually Transmitted Pathogens
pg. 16
Employ Bar Code Technology to Improve Patient Safety
pg. 18
New & Noteworthy
New & Noteworthy

For laboratories with manual workflows that need an efficient, high-speed 2D bar code reader for tube racks, the LabElite I.D. Reader from Hamilton Storage ... read more

Streck introduces UA-Cellular Complete, a urinalysis control with both chemistry analytes and cellular components to more closely mimic a patient sample. ... read more

The FDA has cleared Randox\'s Immunoassay Premium Plus quality control for use in US laboratories. A multi-analyte control, it combines 52 analytes, including ... read more

Gold Standard Diagnostics (GSD), announces new Line Immunoassay technology for Lyme confirmation testing, giving clinical laboratories an FDA-cleared option ... read more

The Linearity FD General Chemistry (for Alfa Wassermann), 5 levels from AUDIT MicroControls is intended to simulate human patient serum samples for the ... read more

Avanti JXN-26 centrifuges from Beckman Coulter Life Sciences can be run from an Apple iOS or Android device using MobileFuge, a mobile application available ... read more

Nouvation recently released an upgrade of its OTIS-Laboratory software system--OTIS 8--to help laboratories drive process improvement and comply with CAP ... read more

The Binding Site announces the availability of a Proteinase-3 (cANCA) native auto-antigen for in-vitro diagnostics (IVD). Designed for use in solid phase ... read more

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register:

    As of May 24, 2018,'s Terms of Use and Privacy Policy have been updated.
    You can review the Terms of Use HERE and the Privacy Policy HERE.
    By continuing to use, you are agreeing to these changes.